Tarsus Pharmaceuticals, Inc. TARS Unrecognized Tax Benefits - Impacting Effective Tax Rate
Unrecognized Tax Benefits - Impacting Effective Tax Rate at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s unrecognized tax benefits - impacting effective tax rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s unrecognized tax benefits - impacting effective tax rate?
- Tarsus Pharmaceuticals, Inc. (TARS) reported unrecognized tax benefits - impacting effective tax rate of $0 in Q4 2025.
- What does unrecognized tax benefits - impacting effective tax rate mean?
- This subset of unrecognized tax benefits represents positions that, if recognized, would directly impact the company's effective tax rate. It highlights the specific portion of tax uncertainty that carries a direct risk to the reported bottom-line tax expense. Investors monitor this to gauge the potential volatility of future tax provisions.